2283: Oncimmune Reports Substantial Growth in their Interim Results & Alan Green on 3 Companies

The SharePickers Podcast with Justin Waite - Un pódcast de Justin Waite

prueba podimo gratis durante 60 días!

prueba podimo gratis durante 60 días!

Miles de audiolibros y podcasts exclusivos, haz clic aquí para probar
Podcast artwork

Categorías:

Economia

Oncimmune reports substantial revenue growth achieved with increased commercial activity across the business and Alan Green discusses Synairgen, Destiny Pharma and Mode Global Holdings

Visit the podcast's native language site